BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NYSE MKT: TXMD) (“TherapeuticsMD” or the “Company”), an innovative women’s healthcare company and parent company of vitaMedMD, LLC (“vitaMedMD”), announced today the launch of vitaMedMD’s newest prescription prenatal multivitamin, vitaTrue, adding to its successful prenatal line consisting of vitaPearl™, vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
VitaTrue offers women with vegan or kosher preferences and who are planning a pregnancy, pregnant, or nursing a complete prenatal multivitamin without compromises. Jason Spitz, Vice President of Marketing, stated, “vitaMedMD has once again listened and responded to the needs of women and the healthcare community for comprehensive nutritional support in the prenatal space, specifically creating a prenatal vitamin that is both certified vegan and certified kosher. Like all vitaMedMD prenatal vitamins, vitaTrue is gluten-free, lactose-free, and sugar-free. Additionally, vitaTrue is fish-free and gelatin-free.”
VitaTrue contains 16 vitamins and minerals, including 40% more folic acid than the leading prescription prenatal vitamins, and 300 mg of vegan, plant-based DHA. VitaTrue is available by prescription through retail and mail order pharmacies nationwide beginning today.
VitaTrue – Stay True to You!
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes two phase 3 products. The company manufactures and distributes branded and generic prescription prenatal vitamins as well as over-the-counter vitamins under the vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: www.therapeuticsmd.com, www.vitamedmdrx.com and www.bocagreenmd.com.
TherapeuticsMD, Inc.
Investors
Dan Cartwright, 561-961-1900
Chief Financial Officer
Dan.Cartwright@TherapeuticsMD.com
or
Media
Elliot Fox, 212-257-6724
Director, Media & Engagement, WCG
efox@w2ogroup.com